State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
Colorectal Cancer (8)Breast Cancer (7)Prostate Cancer (7)Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (5)Melanoma (5)Non-small Cell Lung Cancer (5)Acute Lymphoblastic Leukemia (4)Ovarian Cancer (4)Hematopoietic and Lymphatic System Neoplasm (4)Mantle Cell Lymphoma (3)Mixed Phenotype Acute Leukemia (3)
NCT04195633 Phase 2
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiat...
Condition
Acute Leukemia
Enrollment
60 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT06272864 N/A
Recruiting
BostonGene and Exigent Genomic INsight Study
Condition
Breast Cancer
Enrollment
400 pts
Location
United States
Sponsor
BostonGene
NCT04706663 N/A
Recruiting
Precision-Based Genomics in Prostate Cancer
Condition
Prostate Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05787587 Phase 1
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell M...
Condition
B-cell Malignancy
Enrollment
614 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT06575192 Phase 3
Recruiting
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix...
Condition
Breast Reconstruction
Enrollment
783 pts
Location
United States
Sponsor
AbbVie
NCT06699121 Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Condition
Primary Sclerosing Cholangitis (PSC)
Enrollment
87 pts
Location
United States
Sponsor
LISCure Biosciences
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06479980 N/A
Recruiting
Single Session Narrative Therapy Study
Condition
Mental Health Issue
Enrollment
60 pts
Location
United States
Sponsor
University of Washington
NCT04725422 N/A
Recruiting
CHronic Nonbacterial Osteomyelitis International Registry
Condition
Chronic Nonbacterial Osteomyelitis
Enrollment
2,000 pts
Location
United States
Sponsor
Seattle Children's Hospital
NCT07088419 Phase 2
Recruiting
"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
Condition
Mycoplasma Genitalium
Enrollment
40 pts
Location
United States
Sponsor
University of Washington
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06601933 Phase 2
Recruiting
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Tri...
Condition
Mild Cognitive Impairment (MCI)
Enrollment
240 pts
Location
United States
Sponsor
Columbia University
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT04083183 Phase 1, Phase 2
Recruiting
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for ...
Condition
Non-Malignant Neoplasm
Enrollment
40 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT03878849 Phase 2
Recruiting
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Adv...
Condition
Advanced Ovarian Cancer
Enrollment
40 pts
Location
United States
Sponsor
Allarity Therapeutics
NCT06447168 N/A
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in P...
Condition
Primary Biliary Cholangitis
Enrollment
424 pts
Location
United States, Austria, Canada
Sponsor
Ipsen
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
Page 1 of 11 — 254 trials total